Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

Novel mRNA-based vaccines have been proven to be powerful tools in combating the global
pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently …

Clinical trials have indicated that immunoablation followed by autologous hematopoietic
stem cell transplantation (ASCT) has the potential to induce clinical remission in patients with …

Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS–CoV-2). So far, viral targets of cellular …

Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …

Objectives Recent data debate the suitability of Helios, an Ikaros family member, as a marker
for thymic-derived regulatory T cells (Treg). Nevertheless, Foxp3 + Helios + Treg may be of …

Mucosal‐associated invariant T (MAIT) cells are characterized by an invariant TCRVα7.2
chain recognizing microbial vitamin B metabolites presented by the MHC‐Ib molecule MR1. …

Objective Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX)
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …

Patients with kidney failure have notoriously weak responses to common vaccines. Thus,
immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine …

Background Accumulating evidence sugges ts solid organ transplant recipients, as opposed
to the general population, show strongly impaired responsiveness toward standard SARS-…